Informations:
Erreur:
ID
14195
Description
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's; ODM derived from: https://clinicaltrials.gov/show/NCT00105547
Lien
https://clinicaltrials.gov/show/NCT00105547
Mots-clés
Versions (1)
- 04/04/2016 04/04/2016 -
Téléchargé le
4 avril 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Alzheimer Disease NCT00105547
Eligibility Alzheimer Disease NCT00105547
- StudyEvent: Eligibility
Similar models
Eligibility Alzheimer Disease NCT00105547
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
alzheimers disease
Item
have had a diagnosis of probable alzheimer's disease.
boolean
C0002395 (UMLS CUI [1])
gender; age
Item
men or women ages 55 years or greater and living in the community at the time of enrollment (i.e., not living in a rest home or nursing care facility).
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
informed consent
Item
signed the subject informed consent form and is willing and able to participate for the duration of the study.
boolean
C0021430 (UMLS CUI [1])
english speaking
Item
ability to read and understand english or spanish to ensure compliance with cognitive testing and study visit procedures.
boolean
C0376245 (UMLS CUI [1])
Contraception status; postmenopausal
Item
female subjects must be surgically sterile or postmenopausal for > 1 year.
boolean
C0420837 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
medication alzheimers disease
Item
subjects currently taking approved medication for alzheimer's disease for at least six months prior to day 1 may be enrolled.
boolean
C0013227 (UMLS CUI [1,1])
C0002395 (UMLS CUI [1,2])
C0002395 (UMLS CUI [1,2])
caregiver; english speaking
Item
subjects must have a reliable caregiver who can read, understand and speak english or spanish.
boolean
C0085537 (UMLS CUI [1])
C0376245 (UMLS CUI [2])
C0376245 (UMLS CUI [2])
dementia
Item
current evidence of other causes of dementia.
boolean
C0497327 (UMLS CUI [1])
malignancy; basal cell carcinoma; Squamous cell carcinoma of skin; prostate cancer
Item
history or evidence of, active malignancy, except for basal cell carcinoma or squamous cell carcinoma of the skin, within the 24 months prior to entry. men with prostate cancer may be enrolled at the discretion of the sponsor.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
renal disorder; hepatic disease; metabolic disorder
Item
chronic or acute renal, hepatic or metabolic disorder.
boolean
C0022658 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
C0025517 (UMLS CUI [3])
C0023895 (UMLS CUI [2])
C0025517 (UMLS CUI [3])
immunotherapy; investigational therapy
Item
use of any investigational therapy within 30 days, or 5 half-lives, whichever is longer, and/or use of ad immunotherapy prior to screening.
boolean
C0021083 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
C0949266 (UMLS CUI [2])
major surgery
Item
major surgery and related complications not resolved within 12 weeks prior to day 1.
boolean
C0679637 (UMLS CUI [1])